The startup operates a stem cell bank for pets, enabling the collection and storage of a pet's own stem cells during routine desexing procedures. This service provides pet owners with access to personalized regenerative therapies for conditions such as arthritis and other health issues, potentially extending their pets' quality of life.
Funding
$2.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Many pets, particularly larger breeds, are predisposed to conditions like osteoarthritis and joint pain, which can significantly impact their quality of life. Current treatment options often involve managing symptoms rather than addressing the underlying cause, potentially leading to invasive surgeries or reliance on pharmaceuticals with side effects.
Solution
Elita Genetics offers a proactive solution by providing stem cell banking services for pets, allowing owners to store their pet's own stem cells collected during routine desexing procedures. These autologous stem cells can then be used in future regenerative therapies to treat conditions like osteoarthritis and joint injuries, offering a natural, personalized approach to healing. By banking stem cells early in a pet's life, owners gain access to a growing field of regenerative medicine, potentially unlocking treatments for a wider range of conditions as research advances. This approach empowers veterinarians with more treatment options and provides pet owners with peace of mind, knowing they have secured their pet's future health. Elita Genetics ensures full sterility and strict quality assurance for every sample, aligning with Australian veterinary standards.
Target Audience
The primary target audience includes pet owners, particularly those with pre-desexed puppies or breeds prone to joint issues, who are seeking proactive and personalized healthcare solutions for their pets, as well as veterinarians looking to expand their treatment options with regenerative medicine.
Features
- Stem cell collection during routine desexing procedures, minimizing invasiveness
- Cryopreservation and secure storage of autologous mesenchymal stem cells (MSCs) derived from adipose tissue
- Stem cell retrieval and processing for future therapeutic use
- Biannual updates on relevant advancements in stem cell therapy
- Multiple pricing options, including basic banking with affordable monthly storage and comprehensive plans covering storage and treatment
- Veterinary network for collaboration and access to the latest research and clinical data